Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Other Non-Current Assets: 2014-2024

Historic Other Non-Current Assets for Viking Therapeutics (VKTX) over the last 10 years, with Dec 2024 value amounting to $46,000.

  • Viking Therapeutics' Other Non-Current Assets changed negligibly% to $46,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $46,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $46,000 for FY2024, which is 39.39% up from last year.
  • As of FY2024, Viking Therapeutics' Other Non-Current Assets stood at $46,000, which was up 39.39% from $33,000 recorded in FY2023.
  • Viking Therapeutics' Other Non-Current Assets' 5-year high stood at $46,000 during FY2024, with a 5-year trough of $29,000 in FY2020.
  • Moreover, its 3-year median value for Other Non-Current Assets was $33,000 (2023), whereas its average is $37,333.
  • Data for Viking Therapeutics' Other Non-Current Assets shows a peak YoY surged of 39.39% (in 2024) over the last 5 years.
  • Over the past 5 years, Viking Therapeutics' Other Non-Current Assets (Yearly) stood at $29,000 in 2020, then rose by 13.79% to $33,000 in 2021, then remained steady at $33,000 in 2022, then remained steady at $33,000 in 2023, then surged by 39.39% to $46,000 in 2024.